Showing results (141-150 of 517) with videos related to

Sort By:
Pageof 52
Clinical Lymphoma, Myeloma & Leukemia|June 27, 2025
Monoclonal Gammopathies in AfricaAbiola Bolarinwa, Lateef Odukoya, Francis Buadi, et al.
Oncotarget|October 24, 2018
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myelomaUtkarsh Painuly, Vijay Ramakrishnan, Teresa Kimlinger, et al.
American Journal of Hematology|July 24, 2010
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cellsVijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, et al.
Journal of Blood Medicine|September 2, 2017
New developments in the management of relapsed/refractory multiple myeloma - the role of ixazomibPaul G Richardson, Shaji Kumar, Jacob P Laubach, et al.
Leukemia & Lymphoma|October 7, 2014
Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agentsMorie A Gertz, Evangelos Terpos, Angela Dispenzieri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 12, 2010
Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition diseaseElizabeth C Lorenz, Sanjeev Sethi, Tanya L Poshusta, et al.
Pageof 52